Stocktoria

Bausch Health Companies Inc. BHC

NYSE · stock · Pharmaceutical Preparations · website · IPO 1994-09-20 · LEI

Bausch Health Companies Inc. statistics & valuation

Market cap$2.8B
P / E17.8×
P / S0.3×
P / FCF2.8×
Net margin1.5%
FCF margin9.8%
Net debt$19.5B
Net debt / EBITDA6.5×
Enterprise value USD$22.3B
EV / EBITDA7.4×
Earnings yield EBIT/EV8.1%
Return on capital8.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-20.80% -7.00% -11.20% -2.80% -6.80% -0.50% 1.50% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-5.90% 1.20% -28.40% -2.40% 8.40% 5.30% 5.60% 11.00% 16.10% 17.70% 2016201720182019202020212022202320242025
Return on equity (%)
-157.40% -92.60% 2016201720182019202020212022202320242025
Shares outstanding
347.8M 351.8M 351.3M 352.6M 355.4M 359.4M 362.0M 365.2M 368.0M 375.0M 2016201720182019202020212022202320242025
Net debt ($)
$29.30B $24.72B $23.58B $22.65B $23.32B $22.07B $20.20B $21.44B $20.43B $19.51B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-5.30% -1.80% -3.20% -0.90% -2.20% -0.20% 0.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
19.10% 24.30% 16.00% 14.30% 10.10% 13.70% -11.60% 9.30% 13.10% 9.80% 2016201720182019202020212022202320242025
Debt / equity (×)
9.16× 4.28× 8.63× 22.79× 39.55× 2016201720182019202020212022202320242025
EPS ($)
-$6.94 $6.83 -$11.81 -$5.08 -$1.58 -$2.64 -$0.62 -$1.62 -$0.13 $0.42 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Bausch Health Companies Inc. trades at about 14.8× earnings — below its 10-year norm (10-year range 2.7×–99×, median 62×).

2.7× 99×

Shaded band = 10-year range (2.7×–99×); dot = today's 14.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin17.7%16.1%11.0%5.6%5.3%8.4%-2.4%-28.4%1.2%-5.9%
Net margin1.5%-0.5%-6.8%-2.8%-11.2%-7.0%-20.8%———
FCF margin9.8%13.1%9.3%-11.6%13.7%10.1%14.3%16.0%24.3%19.1%
Return on assets0.6%-0.2%-2.2%-0.9%-3.2%-1.8%-5.3%———
Return on equity-28.3%3.6%57.9%32.5%894.3%-92.6%-157.4%———
Debt / equity-37.58×-16.90×-21.91×-30.01×-213.72×39.55×22.79×8.63×4.28×9.16×
Current ratio1.470.861.301.081.081.091.121.101.111.41

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.